LENEXA, Kansas – RBC Medical Innovations has announced the launch of AdvantageRF Demo Days in celebration of its twentieth year of operation. The experiential product development road show marks another first for the growing Kansas City area based contract medical device design, development, and manufacturing service provider, who recently opened another facility to support their first FDA registered contract manufacturing establishment.

RBC Medical Innovations will be hosting AdvantageRF Demo Days events in an exclusive Tech Suite at the 2014 Medical Design & Manufacturing Conference, October 29th and 30th in the Minneapolis Convention Center. RBC’s RF medical device development team will provide interactive opportunities to experiment with the innovative platform, start the initial development of your treatment profiles, and offer guidance on potential design pathways for optimizing time to market.

After years of proven research and testing, RBC is now offering an advantage for RF medical device developers. AdvantageRF is a portfolio of flexible solution tools that reduce risks, enhance reliability and sustainability, as well as accelerate time to market and lower research & development costs. This unique development platform offers significant advantages as an energy source for medical devices performing ablation, cutting, coagulation, and cauterization. Simply plug-in and you can immediately start developing your RF treatment profiles on a proven RF engine that can shorten your time to market by 50%. AdvantageRF also enables updates, new connected devices and clinical treatments without touching the deployed radio frequency generator.

For more information about how to reserve an exclusive working session with a proven pathway for accelerating your medical device to market and reducing risks visit www.rbccorp.com.

About RBC Medical Innovations

RBC Medical Innovations is ISO 13485 | ISO 9001 certified, FDA registered and has been supporting the contract design, development, and manufacturing of medical devices since 1994. We focus exclusively on designing and producing Class I, II, and III medical devices for US FDA PMA or 510(k) as well as international CE marking. We have the available resources, capabilities and tools to transform your vision into a commercial device that is delivered to market on target, on time, and on budget.

Contact:

Rod Cain
RBC Medical Innovations
13715 West 109th Street
Lenexa, KS 66215
rcain@rbccorp.com